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Abstract 
Background: Socio-cultural factors may influence the uptake of breast cancer treatments. This study aimed to 
explore these socio-cultural influences on treatment decision-making for women in Ghana.
Method: An ethnographic approach was adopted. Observation was conducted of women newly diagnosed with 
breast cancer, nominated relatives, nurses and doctors at a breast clinic in Ghana. Semi-structured interviews followed 
participant observation. Thematic analysis was employed.
Findings: Over 16 weeks (July 2017–November 2017), 31 participants were observed and 29 took part in semi-
structured interviews. Three overarching themes were identified: (1) unequal power relationships; (2) Language bar-
riers and (3) structural constraints. Following a breast cancer diagnosis, essential information necessary for treatment 
decision making is ‘hidden’ from women due to an unequal patient-provider relationship. Patients acknowledged 
cultural behaviours of deference to experts. Doctors deliberately misrepresented treatment information to women 
to encourage them to undergo surgical treatment. Structural issues such as the lack of privacy during consultations 
hindered quality patient engagement with decision-making. High treatment costs and the lack of resources to assist 
women with fertility after treatment impeded open discussions around these issues. Language barriers included a 
lack of terms in the local Twi language to explain cancer and its treatment. There was also an absence of appropriate 
information materials.
Conclusion: Findings highlight the need for health professionals to be aware of the socio-cultural factors that limit 
access to quality information which is needed for informed treatment decision making. Policies that aim to provide 
adequate logistics; increase staffing levels; improve staff cultural awareness training and remove financial barriers are 
recommended.
Keywords: Patient-provider relationships, Socio-cultural factors, Language barriers, Participant observation, 
Qualitative interviews, Ethnography, Decision-making
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Background
Breast cancer is the most frequently diagnosed cancer 
among women worldwide. In 2018, the global estimates 
of breast cancer were 2.1 million new cases [1], with 
approximately 50% in developing countries [2]. In Ghana, 
and comparable low- and middle-income countries in 
sub-Saharan Africa, over 60% of women have advanced 
(stage 3 and 4) breast cancer at diagnosis [3, 4] compared 
to approximately 33% in higher income countries like the 
USA [5].
Estimates for the five-year survival rate for breast can-
cer in Ghana is 39% [6] compared to 91% in the USA [7]. 
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However, the absence of a Ghanaian national cancer reg-
istry means rates may be under-reported.
The influence of culture on health behaviours has long 
been documented in the literature [8]. Previous studies 
have identified prevalence of traditional healing modali-
ties as contributors to delayed diagnosis and treatment 
among Ghanaian women [9, 10]. Socio-cultural factors 
that may influence women’s decision making include cul-
tural beliefs that breast cancer has supernatural causes, 
that mastectomy inevitably leads to death; that a woman 
cannot be ‘complete’ following mastectomy; and the 
centrality of God to healing [10–14]. Stigma attached to 
breast cancer diagnosis and mastectomy as well as finan-
cial constraints have been shown to delay treatment [13, 
15].
Studies conducted in Africa highlight how socio-cul-
tural factors inhibit the timely uptake of breast cancer 
treatment [9–15]. However, little is known about how 
these factors shape the involvement of women in the 
decision-making processes. The aim of this study is to 
explore and understand how the cultural context influ-
ences the decision-making process for women attending 
a breast clinic in southern Ghana.
Methodology
An ethnographic approach was adopted. Data collection 
involved observation of the interactions between clini-
cians and women and their relatives as they navigated 
the breast clinic and received their diagnosis and treat-
ment recommendations. Semi-structured interviews 
then explored what had been observed with participants 
in greater depth.
Setting
The study took place in a public teaching hospital in 
Southern Ghana that provided comprehensive breast 
cancer management. The hospital is the regional centre 
for cancer treatment and breast cancer is the most com-
mon cancer presented there [16]. As a referral point for 
the Northern, Middle, Western and Central parts of the 
country, the clinic is accessed by a heterogeneous group 
of people.
Sample
Purposive maximal variation sampling was used to sam-
ple women whose treatment had curative intent (up to 
stage 3 breast cancer); women-nominated family mem-
bers; nurses; and doctors at a breast clinic in southern 
Ghana. The study focused on two time points, firstly at 
formal diagnosis (where core biopsy reports were availa-
ble to patients), and secondly at a tumour board meeting, 
where ‘women’s treatment options were discussed’.
Data collection
Participant observation was conducted by LA (July 
2017 to November 2017). Observation concentrated 
on the information women received and the dynamics 
between healthcare professionals (HCPs), women with 
breast cancer and their family members (i.e., seating 
arrangements, who led the discussions, verbal and non-
verbal communication).
Focused observations mostly lasted between one and 
four hours on a clinic day and continued until data satura-
tion when no new insights emerged. Field notes were kept 
during participant observation and women and their nom-
inated relatives were interviewed following their tumour 
board meeting, when treatment options were discussed. 
Some HCPs were interviewed half-way through partici-
pant observation (to allow for concurrent preliminary data 
analysis) and others towards the end. All participant inter-
views followed an interview guide (Appendix 2–4).
Interviews were conducted mostly in Twi, a local 
Ghanaian Language, unless participants chose to speak 
in English. For the patients and their family members, 
interviews were conducted either at the clinic, their 
homes or workplaces, and clinicians’ interviews were 
conducted in the clinic setting [17, 18]. Interviews were 
audio recorded and field notes were recorded describ-
ing conversations, descriptions of the context, and per-
sonal reflections. Interview audio recordings were first 
transcribed verbatim in Twi and later translated into 
English by LA, with the accuracy of translations vali-
dated by a local expert. Each participant was assigned 
an exclusive pseudonym [19].
Data analysis
Thematic analysis was conducted on data from both the 
observations (field notes) and interviews using NVivo 
12 (computer assisted data analysis software) [19, 20].
Reflexivity
LA is a registered nurse and a native Twi speaker, but 
she was not known to the study participants before 
undertaking the study.
Ethics
Ethical approval was obtained from Kwame Nkru-
mah University of Science and Technology (Reference: 
CHRPE/AP/393/17) and University of Southampton 
(Ethics ID: 26,346). Participants were provided with 
information sheets outlining the study aim and research 
process after which written consent was obtained. Par-
ticipants were informed of their right to refuse partici-
pation [21].
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Findings
A total of 89 h of participant observation was conducted at 
the breast clinic over a 40-day period. 31 participants were 
observed: 16 women with breast cancer stage 1–3; five 
self-nominated family members; ten HCPs, including five 
nurses; and five doctors. Of the 31 participants (Table 1), 
29 were interviewed and two HCPs were not interviewed 
following observation due to time constraints and work 
demands.
‘Hidden information’
During patient-clinician interactions, important informa-
tion about the disease stages and treatment, (expected 
outcomes, risks, and benefits) were rarely provided. For 
instance, when patients and relatives described their views 
on diagnosis and treatment, most reported they received 
little information about the disease and treatment. A few 
commented:
“when I came, I have not been told much, so cancer I 
don’t know anything” (Foriwaa, 48 years)
“Umm they did not say much, they just said they will 
give drugs and then they will do operation for her” 
(Maame Saa’s son, 29 years).
This perspective was corroborated by observations of 
the organised tumour board meetings where patients and 
relatives were invited, but are then asked to wait outside, 
whilst HCPs discuss their treatments in their absence. As 
patients are rarely involved in treatment discussions, they 
often report feeling disempowered and have little knowl-
edge about their disease or the treatment options available 
to them.
“I was expecting the doctor to talk to me when I do the 
test, but he did not say anything…mmm, no one really 
tells me anything, even the day I went to the [Tumour 
Board] meeting, we sat waiting for a long time, it was 
later the nurse came to tell me I will be coming to 
oncology for some injection, so I have not been able to 
talk to anyone, I don’t really know what the treatment 
will involve” (Maame Tawia, 52 years).
The ‘hidden’ nature of information about breast cancer 
and its treatment was influenced by three main themes: 
unequal power relationships, language barriers and struc-
tural constraints (see Table 2).
Unequal power relationships
Passivity and deference to HCPs
Patients often reported they would rather defer to the 
greater expert knowledge of HCPs and were unlikely to 
ask questions even if they did not understand something.
“Umm madam, I know if anything at all it is doctors 
who are going to do everything, so I did not ask ques-
tion” (Lydia, 45 years).
Their perceived need to acquiesce to authority there-
fore reinforced their silence. Patients feared that asking 
HCPs questions or raising concerns may be interpreted 
as challenging the authority, competence and profession-
alism of staff and cause them to receive poorer care.
“so, I don’t do anything that will sound that I am 
challenging them and be asking too much questions, 
so I need to come down so they also take care of me” 
(Maame Abigail, 68 years)
Deliberate miscommunication of treatment intent
HCPs were aware of the misconceptions and the cultural 
beliefs regarding the spiritual origins of cancer which 
prevented women from proceeding with treatment. They 
sometimes used ambiguous rather than specific terms, 
such as, ‘operation’ rather than ‘mastectomy’, to hide the 
actual treatment intent and to influence the behaviour of 
women and prevent them from refusing treatment.
“using ‘operation’ is intentional, we don’t want them 
to run away” (comment from a doctor as recorded in 
the Field note).
“he just called one after the other and said some-
thing briefly that I will have drugs after they will do 
operation and remove it for me, … he did not say he 
will cut the breast, he said he will remove the lump” 
(Foriwaa, 48 years).
The deliberate miscommunication of the proposed 
treatment effectively ‘hides’ such information from 
patients. Other HCPs, however, did not support this 
approach and encouraged their colleagues to be open 
about their intended treatments.
Language barriers and limitations in the local language 
to describe cancer
The diagnosis provided to women was defined as ‘can-
cer’ or ‘kokoram’. The word ‘cancer’ is an English word 
and although English is spoken in Ghana as a second 
language, it is learned during formal education. Hence, 
people without formal education may have difficulty 
understanding what ‘cancer’ means. ‘Kokoram’ is the 
local Twi word for cancer, but there are over 40 lan-
guages spoken in Ghana which all are limited in the 
words they have to describe cancer. As women who 
present to the clinic are ethnically diverse, this lack 
of appropriate language terms constitutes a barrier to 
their understanding.
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Table 1 Characteristics of participants
Participant Characteristics Category of characteristics Number of participants







Number of children None 2
1–3 9











Education No formal education 3
Primary or elementary 9
Secondary 1
Tertiary 3







Breast cancer stage Stage 2 7
Stage 3 9
Recommended treatment Breast conservation, adjuvant 1
Mastectomy 1
Mastectomy, adjuvant 3
Neoadjuvant, mastectomy, adjuvant 11




Education of relative participant Primary or elementary 3
Secondary 1
Tertiary 1






Healthcare professionals (n = 10) Professional/clinical role Consultant general surgeon 2
Resident 3
Adult general nurse 4
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Secondly, there are also no words to explain certain con-
cepts (types of breast cancer; cancer staging; chemother-
apy; radiotherapy; hormonal; and biologic therapies). The 
lack of definitive words was evident during interactions 
between patients and HCPs. For example, it was observed 
that chemotherapy was referred to as ‘cancer injections’ 
and radiotherapy as ‘heat’ by staff. The limited concepts 
to explain cancer and treatment limits the understand-
ing amongst patients and constrains decision making. A 
third issue relating to language is the content of posters at 
the clinic which are largely in English and inaccessible to 
patients and relatives with limited formal education. Fur-
thermore, investigation results are coded in medical terms 
and so people with little or no health literacy background 
may find them challenging to understand. One patient 
relative commented:
“Umm they have not said anything whether it is 
this or that. [The doctor] said they will give drugs 
and then they will do operation for her, but the 
tests we went to do, I read the report and it says 
there is nothing but the histology report too when 
I read, I could not really make anything out” 
(Maame Saa’s son, 29 years).
Overall, the effect of the limitations of language and 
terminology in this context limits access or ‘hides’ qual-
ity information about breast cancer and treatment from 
patients and relatives.
Structural barriers that reinforce gaps in knowledge 
about the disease and treatment
Under resourced clinic
Limited expertise in breast cancer amongst HCPs, as well 
as the inadequate number of staff and consulting rooms, 
meant the capacity for effective patient-clinician interac-
tions was also limited. Two nurses mentioned that they 
were unable to engage patients and provide them with 
the necessary information due to time constraints and 
workload.
“we should talk to them and give information for 
them to understand, but we don’t normally or regu-
larly do it because of time or workload” (Nurse C)
The doctors also mentioned the problem that ‘the job 
is plenty’ [ie demanding] for them because they are not 
breast specialists but general surgeons, which meant they 
had other commitments from other surgery clinics.
“here we are not breast specialists, if we do breast 
today, tomorrow we are doing hernia, the next day 
goitre, the next day stomach cancer so it does not 
make the focus to be solely on the breast…” (Dr C)
Many of the patients mentioned that following a life-
threatening diagnosis, they reacted with sadness, con-
fusion and fear, which meant they were unreceptive to 
information or unable to ask for clarification at the time 
of diagnosis. Hence, two patients reported they would 
have liked to have a follow-up contact with staff, which 
was absent.
“on that day, when the doctor told me about the 
results that it is cancer, hmm, all that I was think-
ing about was I am coming to die, therefore, all the 
things he said afterwards I did not hear anything at 
all. I heard him talking, but none made any mean-
ing to me because all that kept coming back to my 
mind was the word cancer…so when I went home, I 
felt there is no telephone number to call but I wanted 
more information later on…” (Adwoa, 32 years).
Table 1 (continued)
*Daily minimum wage in Ghana is approximately Two US Dollars (Africa Labour Research and Education Institute, 2021)
Table 2 Themes and sub-themes relating to ‘hidden’ information
Theme Sub-theme
Unequal power relationships (i) Passivity and deference to HCPs
(ii) Deliberate miscommunication 
of treatment intent
Language barriers
Structural constraints (i) Under resource of the breast clinic
(ii) Lack of discussion about costs
(iii) Limited discussions about fertility
Participant Characteristics Category of characteristics Number of participants
Nurse/Midwife 1
Years in service 10 or more 3
> 5 < 10 3
Up to 5 4
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Both patients and doctors were not able to discuss 
sensitive information due to frequent interruptions and 
often the presence of other patients in the same con-
sulting room. This issue was reported in some of the 
interviews:
“Mmm, the people in the consulting room were 
many, they keep coming to interrupt and ask him 
something and I was thinking me too I want to ask 
this question, but these people keep coming to the 
doctor to show him things, so the doctor did not get 
time, he could not get any time” (Maame Tawia, 52 
years)
The lack of quality engagement with clinicians left 
patients feeling disempowered and lacking understanding 
and information of their condition and treatment options.
Lack of discussion about costs
Both HCPs and patients acknowledged that investigation 
costs are one of the biggest challenges to patients adher-
ing to treatment. HCPs therefore found discussions with 
women about treatment costs uncomfortable because 
they knew they were often unaffordable. The doctors 
often avoided such discussion if possible and delegated 
this task to the nursing staff.
“…Now what I am going to do is to write some inves-
tigation request for you to do. You will need to have 
chest CT, abdominal ultrasound, …. Do you have 
any questions?” Sara looks at doctor D as he talks 
and then replies, “how much do the things you are 
asking me to do cost?” Dr D (looks at Sara), “I do not 
know but the nurses may be able to assist you”. Field 
note
Similarly, the nurses do not divulge this information 
either, but rather ask patients to check at the various 
departments where the investigations are performed. 
Women therefore navigate the clinic with limited 
information on the cost of requested investigation or 
treatments.
Limited discussion about fertility issues
In Ghana, breast cancer is usually diagnosed among 
women who are young, some of whom are yet to get mar-
ried or have children. HCPs acknowledged that child-
bearing is highly valued in Ghanaian society and reported 
that women often decided against undergoing treatment 
due to their concerns about its impact on fertility.
“childbearing is important in this setting, so it is also 
a problem we face…some don’t come back when we 
tell them treatment can delay or prevent childbear-
ing and we don’t have resources to help women to 
conceive after treatment in this hospital” (Doctor E)
A few of the women raised concerns about not know-
ing how their fertility will be impacted by treatment.
“I was thinking about childbearing, that what if, so I 
am thinking will the chemo affect my ability to have 
other children. … but it seems the way the doctors 
were asking me, do I have only one child, so it seems 
there is a question mark somewhere that they don’t 
want to bring it out” (Natasha, 28 years).
The lack of honest discussion meant patients’ concerns 
around fertility were not adequately addressed. This left 
gaps in their knowledge which could create avenues 
for misinformation and a consequent loss of women to 
follow-up.
“So, if women are not able to ask questions and we 
also don’t give much information, it contributes to 
us losing them because there is a lot of misinforma-
tion. What I will say lot of gaps, so they begin to fill 
in the gaps themselves with wrong information, … 
then if that information happens to be wrong then 
that is it, we lose them” (Dr D).
Discussion
These findings demonstrate that following a diagno-
sis of breast cancer, cultural and structural factors ‘hide 
information’ regarding treatment options for Ghanaian 
women which is detrimental to their decision making. A 
culture of hierarchy and deference ensured women were 
passive and deferred to HCPs as the ‘experts’ regarding 
their treatment decisions, a finding in previous research 
[22]. The limited discussions between patients and HCPs 
left patients susceptible to misleading information from 
other sources. Anarado et  al. [23] had a similar finding, 
where lack of information and support from nurses cre-
ated gaps that threatened adherence to prescribed chem-
otherapy courses among Nigerian women with breast 
cancer.
High levels of deference to authority figures reflects 
the hierarchical nature of Ghanaian society [24]. Within 
social settings, seniors are viewed as wise and should 
be consulted by others when making decisions [24, 25]. 
It is believed that as doctors have acquired wisdom and 
expert knowledge from education [24], patients should 
defer to their judgement and allow doctors to make deci-
sions that affect patients’ interests [24].
Unlike the shared decision-making model practised 
in many western countries [26], the socially hierarchi-
cal practices in Ghanaian society limits patients’ active 
involvement and participation in discussions about their 
treatment options. A finding unique to this study was the 
Page 7 of 9Agyemang et al. BMC Women’s Health          (2021) 21:364  
practice amongst HCPs of consciously misrepresenting 
the treatment intent to women with the aim of influenc-
ing their decisions. It was evident in the study that the 
hiding of treatment intent (especially mastectomy), often 
until the last moment before the patient was due to have 
surgery, could be shocking to the woman. It could also 
mean the woman may not have had the chance to grieve 
[27] the potential loss of the breast, which might deter 
her from persevering with the surgery. HCPs should be 
aware of the constraining effects of hierarchical practices 
and encourage patients to express their opinions and 
preferences, and should also minimise interruptions at 
the clinic.
In addition to cultural factors, resource constraints 
also limited the ability of women to participate in the 
treatment decision-making process. Previous studies 
in Ghana [15] and Nigeria [11] have also shown limited 
resources influenced breast cancer treatment uptake. In 
the present study, the teaching hospital where the breast 
clinic was located was a referral hospital for malignant 
cases for over 10 million people living in the northern, 
middle and some southern parts of the country [28]. The 
clinic can hence be overwhelmingly busy for the limited 
number of staff to effectively engage with patients.
The World Health Organization has emphasised the 
suffering of patients with cancer in developing countries 
due to the limited resources [29]. For example, patients 
in this study were not given any specialist attention, par-
ticularly with regards to their psychological concerns 
and emotional needs [12]. Language also represented a 
barrier to understanding [30]. Although both HCPs and 
patients communicated in the same language (despite 
some differences in ethnic background), there were nev-
ertheless limited concepts in the local language to explain 
breast cancer and the various treatment approaches. 
In the present study, three-quarters of the 16 women 
had either basic or no formal education at all: a propor-
tion similar to that reported in the census report from 
the Ghana Statistical Survey in 2010 [28]. In the census 
report, the literacy rate amongst women 15  years and 
older was 49.8% [28]. Limited formal education may 
impact on effective patient-clinician interaction and can 
limit patients’ understanding of medical matters, a find-
ing in previous studies in Nigeria [31] and Ghana [32]. 
These linguistic factors construct a further barrier which 
‘hides’ information from women that could otherwise 
empower them. It is likely that women will seek to fill 
the consequent gaps in their knowledge with more easily 
accessible misinformation and misconceptions, such as 
‘mastectomy equals death’, that could be harmful for their 
decision making.
This issue has implications for policymakers and cli-
nicians. At the level of the clinic, HCPs would require 
more training to increase their awareness about the 
issues impacting breast cancer treatment decision mak-
ing. Although some of the issues (financial barriers, for-
mal education; accessibility to health information and 
language) are outside the control of HCPs, they never-
theless need to be aware of the vulnerabilities of patients 
who visit the clinic and create an enabling atmosphere to 
engage patients and explore their concerns. HCPs could 
further collaborate with patients and survivors of breast 
cancer to provide enhanced supplementary information 
in appropriate formats (e.g., videos and pictures). Policy 
makers should allocate more funding towards cancer 
care and research as advocated by the WHO [33].
The study’s strength is derived from a prolonged 
engagement in the field. In addition, the study involved 
more than one group of participants (i.e., patients, 
families, HCPs), which facilitated triangulation and 
a broader understanding of the different contextual 
aspects impacting breast cancer treatment uptake. The 
status of the researcher in the field as both an insider 
and outsider (a Ghanaian nurse but not a member of 
the clinic team) were a strength for this study, which 
involved an understanding of the common local lan-
guage and ensured relationships of trust could develop 
with study participants.
Despite these strengths, recruitment from a single hos-
pital was a limitation for this study as patients who were 
not able to attend this hospital could not be included.
Conclusion and future research
Sub-optimal treatment is a challenge to breast cancer con-
trol in Ghana. Cultural and structural factors ‘hide’ essen-
tial information necessary for effective decision making, 
which may reduce the uptake of treatment. The findings 
of this study could therefore serve as a needs’ analysis for 
a decision support interventional study in the near future.
Appendix 1
Observation guide
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Appendix 2
Interview guide for patient participant
Background information
Age Marital status Menstruation status
Parity Ethnicity Place of residence
Occupation Income Religion
Educational level
1 . Can you describe your thoughts about what the doctor 
and the nurse talked to you concerning breast cancer 
and treatment? Prompts: How clear are you about the 
pros and cons that are important to you concerning 
the treatment? What information did you want? Did 
you ask questions or clarification? Tell me more?
2. What concerns do you have about the disease and 
treatment? Prompts: Who did you share these con-
cerns with? Tell me more?
3. Ask about behaviour the researcher observed; ask 
about meaning of behaviour observed; how does this 
experience influence your treatment decision?
Appendix 3
Interview guide for relative participant
Age Ethnicity
Relationship to patient Educational level
Income
1 . Can you share with me your views about breast can-
cer and treatment?
2. Can you tell me your concerns about breast cancer 
treatment (prompt: How do your views and concerns 
about breast cancer and treatment influence your 
support to the woman i.e. informational support, 
instrumental support, emotional support?)
3. How do you describe your role in the woman’s treat-
ment decision making?
Appendix 4
Interview guide for HCP participant
Background information
i. Professional background ii. Years of practice at the breast 
clinic
1. Can you describe your role during breast cancer 
diagnosis to women attending this clinic? (prompt: 
how do you provide diagnosis)
2. Can you describe your role during treatment recom-
mendation to women with breast cancer? (prompt: 
how do you offer treatment recommendation)
3. Can you describe what patients’ views are regarding 
breast cancer and treatment? (prompt: in what ways 
does this influence patient decisional support)
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